alpha-cure limited

alpha-cure limited Company Information

Share ALPHA-CURE LIMITED
Live 
MatureMidLow

Company Number

03191947

Industry

Manufacture of electric lighting equipment

 

Directors

Steve Haines

Mark Slater

View All

Shareholders

alpha-cure group ltd

baier uv gmbh

Group Structure

View All

Contact

Registered Address

leonard house great central way, woodford halse, daventry, northamptonshire, NN11 3PZ

alpha-cure limited Estimated Valuation

£5.5m

Pomanda estimates the enterprise value of ALPHA-CURE LIMITED at £5.5m based on a Turnover of £9.1m and 0.6x industry multiple (adjusted for size and gross margin).

alpha-cure limited Estimated Valuation

£6.4m

Pomanda estimates the enterprise value of ALPHA-CURE LIMITED at £6.4m based on an EBITDA of £1.3m and a 4.78x industry multiple (adjusted for size and gross margin).

alpha-cure limited Estimated Valuation

£7.7m

Pomanda estimates the enterprise value of ALPHA-CURE LIMITED at £7.7m based on Net Assets of £4.3m and 1.77x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Alpha-cure Limited Overview

Alpha-cure Limited is a live company located in daventry, NN11 3PZ with a Companies House number of 03191947. It operates in the manufacture of electric lighting equipment sector, SIC Code 27400. Founded in April 1996, it's largest shareholder is alpha-cure group ltd with a 75% stake. Alpha-cure Limited is a mature, mid sized company, Pomanda has estimated its turnover at £9.1m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Alpha-cure Limited Health Check

Pomanda's financial health check has awarded Alpha-Cure Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2.5out of 5
positive_score

1 Strong

positive_score

5 Regular

positive_score

6 Weak

size

Size

annual sales of £9.1m, make it smaller than the average company (£12.1m)

£9.1m - Alpha-cure Limited

£12.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (4.5%)

2% - Alpha-cure Limited

4.5% - Industry AVG

production

Production

with a gross margin of 39.4%, this company has a comparable cost of product (35.1%)

39.4% - Alpha-cure Limited

35.1% - Industry AVG

profitability

Profitability

an operating margin of 13.4% make it more profitable than the average company (7%)

13.4% - Alpha-cure Limited

7% - Industry AVG

employees

Employees

with 54 employees, this is similar to the industry average (59)

54 - Alpha-cure Limited

59 - Industry AVG

paystructure

Pay Structure

on an average salary of £42.9k, the company has an equivalent pay structure (£46.5k)

£42.9k - Alpha-cure Limited

£46.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £167.9k, this is equally as efficient (£187.3k)

£167.9k - Alpha-cure Limited

£187.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 55 days, this is near the average (53 days)

55 days - Alpha-cure Limited

53 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 18 days, this is quicker than average (30 days)

18 days - Alpha-cure Limited

30 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 130 days, this is more than average (106 days)

130 days - Alpha-cure Limited

106 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (12 weeks)

5 weeks - Alpha-cure Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 60.6%, this is a higher level of debt than the average (48.5%)

60.6% - Alpha-cure Limited

48.5% - Industry AVG

ALPHA-CURE LIMITED financials

EXPORTms excel logo

Alpha-Cure Limited's latest turnover from December 2023 is £9.1 million and the company has net assets of £4.3 million. According to their latest financial statements, Alpha-Cure Limited has 54 employees and maintains cash reserves of £725.9 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover9,068,8799,907,4319,593,2188,670,1898,403,36810,418,88711,358,73611,035,4409,231,5056,910,9297,779,5614,760,3313,863,7404,114,8720
Other Income Or Grants000000000000000
Cost Of Sales5,500,0646,135,2005,555,0875,469,6575,075,6347,250,3787,993,7987,688,4706,172,1794,544,7725,135,4133,172,7342,539,5472,685,7830
Gross Profit3,568,8153,772,2314,038,1313,200,5323,327,7343,168,5093,364,9383,346,9703,059,3262,366,1562,644,1481,587,5971,324,1921,429,0890
Admin Expenses2,353,1012,044,9991,707,7681,631,6761,791,9652,838,6062,780,6963,509,9523,091,3232,589,1202,850,1331,692,7381,029,3871,201,874-1,067,097
Operating Profit1,215,7141,727,2322,330,3631,568,8561,535,769329,903584,242-162,982-31,997-222,964-205,985-105,141294,805227,2151,067,097
Interest Payable61,50634,30530,56930,42133,74200000000488488
Interest Receivable411,326668,1510012857061625328955527871685432128
Pre-Tax Profit1,565,5342,361,0782,909,2781,538,4351,502,155330,473584,858-162,729-31,708-222,909-205,458-104,270295,489227,1601,066,738
Tax-187,034-190,601-317,095-178,271-81,340-62,790-111,12300000-76,827-63,605-298,686
Profit After Tax1,378,5002,170,4772,592,1831,360,1641,420,815267,683473,735-162,729-31,708-222,909-205,458-104,270218,662163,555768,051
Dividends Paid657,0671,828,5511,869,884900,400780,4000000000000
Retained Profit721,433341,926722,299459,764640,415267,683473,735-162,729-31,708-222,909-205,458-104,270218,662163,555768,051
Employee Costs2,317,5212,257,7971,928,4251,799,4711,588,0461,993,7391,817,7841,563,9522,147,8401,440,9821,747,7851,072,000940,0131,047,2930
Number Of Employees54595753514843405941523228320
EBITDA*1,335,6711,837,8942,435,9631,669,0521,639,996433,473685,797-58,46349,281-145,295-133,541-15,481381,149301,8641,145,260

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets673,832635,880574,520613,558581,590633,622546,545541,026413,795353,859293,718470,066454,068434,776421,646
Intangible Assets6659531,2411,5291,8172,1052,3932,6812,9693,2573,5453,8334,1214,4094,697
Investments & Other4,814,0004,814,0004,814,0004,814,0004,814,0000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets5,488,4975,450,8335,389,7615,429,0875,397,407635,727548,938543,707416,764357,116297,263473,899458,189439,185426,343
Stock & work in progress1,969,0092,131,8061,817,2661,312,9401,285,6781,098,511853,383817,643871,147703,229788,213799,290647,348397,640425,641
Trade Debtors1,385,7231,568,4901,548,0831,566,8191,423,6262,290,1722,464,7862,353,3141,794,8161,502,7881,809,279847,629847,935989,7941,331,561
Group Debtors1,248,192855,541804,794756,763810,6660000000000
Misc Debtors185,34275,564114,725136,989109,178000051,47639,47145,2117,2381,24727,228
Cash725,890388,385224,610237,46400152,05994,476108,3177,42314,525196,203152,230121,63551,273
misc current assets000000000000000
total current assets5,514,1565,019,7864,509,4784,010,9753,629,1483,388,6833,470,2283,265,4332,774,2802,264,9162,651,4881,888,3331,654,7511,510,3161,835,703
total assets11,002,65310,470,6199,899,2399,440,0629,026,5554,024,4104,019,1663,809,1403,191,0442,622,0322,948,7512,362,2322,112,9401,949,5012,262,046
Bank overdraft238,370000194,0420000000000
Bank loan000000000000000
Trade Creditors 276,577168,24372,4329,032135,9802,671,6852,993,6093,162,1292,356,3191,736,7911,634,6111,172,262729,368726,6761,164,209
Group/Directors Accounts5,399,5025,546,5015,493,3165,809,1495,714,24300000922029,45730,8490
other short term finances045,00034,10732,78328,7100000000000
hp & lease commitments17,07410,00033,93534,44617,6050000000000
other current liabilities526,370926,698858,034808,472596,6060000000000
total current liabilities6,457,8936,696,4426,491,8246,693,8826,687,1862,671,6852,993,6093,162,1292,356,3191,736,7911,635,5331,172,262758,825757,5251,164,209
loans0025,89357,21783,79000000000015,000
hp & lease commitments24,0190024,05858,5040000000000
Accruals and Deferred Income000000000000000
other liabilities0000076,10935,209125,839171,193193,714414,29838,43886,162172,359248,494
provisions182,192157,061106,332112,014103,948111,90493,31997,87877,50973,79658,280105,434117,58587,91166,192
total long term liabilities206,211157,061132,225193,289246,242188,013128,528223,717248,702267,510472,578143,872203,747260,270329,686
total liabilities6,664,1046,853,5036,624,0496,887,1716,933,4282,859,6983,122,1373,385,8462,605,0212,004,3012,108,1111,316,134962,5721,017,7951,493,895
net assets4,338,5493,617,1163,275,1902,552,8912,093,1271,164,712897,029423,294586,023617,731840,6401,046,0981,150,368931,706768,151
total shareholders funds4,338,5493,617,1163,275,1902,552,8912,093,1271,164,712897,029423,294586,023617,731840,6401,046,0981,150,368931,706768,151
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit1,215,7141,727,2322,330,3631,568,8561,535,769329,903584,242-162,982-31,997-222,964-205,985-105,141294,805227,2151,067,097
Depreciation119,669110,374105,31299,908103,939103,282101,267104,23180,99077,38172,15689,37286,05674,36177,875
Amortisation288288288288288288288288288288288288288288288
Tax-187,034-190,601-317,095-178,271-81,340-62,790-111,12300000-76,827-63,605-298,686
Stock-162,797314,540504,32627,262187,167245,12835,740-53,504167,918-84,984-11,077151,942249,708-28,001425,641
Debtors319,66231,9937,031117,10153,298-174,614111,472558,498240,552-294,486955,91037,667-135,868-367,7481,358,789
Creditors108,33495,81163,400-126,948-2,535,705-321,924-168,520805,810619,528102,180462,349442,8942,692-437,5331,164,209
Accruals and Deferred Income-400,32868,66449,562211,866596,6060000000000
Deferred Taxes & Provisions25,13150,729-5,6828,066-7,95618,585-4,55920,3693,71315,516-47,154-12,15129,67421,71966,192
Cash flow from operations724,9091,515,9641,714,7911,439,402-628,864-3,170254,383262,722264,052351,871-663,179225,653222,848218,194292,545
Investing Activities
capital expenditure00000-190,359-106,786-231,462-140,926-137,522104,192-105,370-105,348-87,491-504,506
Change in Investments00004,814,0000000000000
cash flow from investments0000-4,814,000-190,359-106,786-231,462-140,926-137,522104,192-105,370-105,348-87,491-504,506
Financing Activities
Bank loans000000000000000
Group/Directors Accounts-146,99953,185-315,83394,9065,714,2430000-922922-29,457-1,39230,8490
Other Short Term Loans -45,00010,8931,3244,07328,7100000000000
Long term loans0-25,893-31,324-26,57383,79000000000-15,00015,000
Hire Purchase and Lease Commitments31,093-23,935-24,569-17,60576,1090000000000
other long term liabilities0000-76,10940,900-90,630-45,354-22,521-220,584375,860-47,724-86,197-76,135248,494
share issue0000288,000000000000100
interest349,820633,846-30,569-30,421-33,61457061625328955527871685-56-360
cash flow from financing188,914648,096-400,97124,3806,081,12941,470-90,014-45,101-22,232-221,451377,309-76,310-86,904-60,342263,234
cash and cash equivalents
cash337,505163,775-12,854237,4640-152,05957,583-13,841100,894-7,102-181,67843,97330,59570,36251,273
overdraft238,37000-194,042194,0420000000000
change in cash99,135163,775-12,854431,506-194,042-152,05957,583-13,841100,894-7,102-181,67843,97330,59570,36251,273

alpha-cure limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for alpha-cure limited. Get real-time insights into alpha-cure limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Alpha-cure Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for alpha-cure limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in NN11 area or any other competitors across 12 key performance metrics.

alpha-cure limited Ownership

ALPHA-CURE LIMITED group structure

Alpha-Cure Limited has 1 subsidiary company.

Ultimate parent company

1 parent

ALPHA-CURE LIMITED

03191947

1 subsidiary

ALPHA-CURE LIMITED Shareholders

alpha-cure group ltd 75%
baier uv gmbh 25%

alpha-cure limited directors

Alpha-Cure Limited currently has 4 directors. The longest serving directors include Mr Steve Haines (Apr 1996) and Mr Mark Slater (Aug 1996).

officercountryagestartendrole
Mr Steve HainesEngland63 years Apr 1996- Director
Mr Mark SlaterEngland56 years Aug 1996- Director
Mr Shane AtherstoneEngland65 years Oct 1996- Director
Herr Karl-Heinz BaierEngland69 years Jan 2009- Director

P&L

December 2023

turnover

9.1m

-8%

operating profit

1.2m

-30%

gross margin

39.4%

+3.36%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

4.3m

+0.2%

total assets

11m

+0.05%

cash

725.9k

+0.87%

net assets

Total assets minus all liabilities

alpha-cure limited company details

company number

03191947

Type

Private limited with Share Capital

industry

27400 - Manufacture of electric lighting equipment

incorporation date

April 1996

age

29

incorporated

UK

ultimate parent company

accounts

Full Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

CED ACCOUNTANCY SERVICES LIMITED

address

leonard house great central way, woodford halse, daventry, northamptonshire, NN11 3PZ

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

HOWES PERCIVAL

alpha-cure limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 7 charges/mortgages relating to alpha-cure limited. Currently there are 2 open charges and 5 have been satisfied in the past.

alpha-cure limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ALPHA-CURE LIMITED. This can take several minutes, an email will notify you when this has completed.

alpha-cure limited Companies House Filings - See Documents

datedescriptionview/download